News

Diabetes and weight loss drug semaglutide may also treat liver disease
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Health on MSN6h
Ozempic Shows Promise in Treating a Severe Form of Liver Disease, Study Finds
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Rolling Out6h
How to protect your liver from the MASH threat danger
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
Altimmune, Inc. (ALT) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsLee Roth - President, Burns McClellan, ...
Liver Fibrosis Market To Witness Rapid Growth At A CAGR Of ~24% During The Forecast Period (2025-2034) With Emerging Treatment Options Delveinsight
DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...
Altimmune outlines phase 3 pemvidutide plans and expands to alcohol-related liver indications while extending cash runway
Altimmune's Q1 2025 earnings call highlights breakthroughs in NASH treatments, robust financials with a new $100M credit facility, and imminent Phase ...
Galmed Pharmaceuticals Ltd.: Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models
Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads ...